Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its earnings results on Friday. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.02, Zacks reports.
Anixa Biosciences Stock Performance
Anixa Biosciences stock remained flat at $2.25 during midday trading on Friday. The company had a trading volume of 47,021 shares, compared to its average volume of 75,354. The firm has a market capitalization of $72.40 million, a P/E ratio of -5.77 and a beta of 0.90. The stock's 50-day moving average price is $2.92 and its 200-day moving average price is $3.02. Anixa Biosciences has a twelve month low of $2.14 and a twelve month high of $5.13.
Wall Street Analyst Weigh In
Several research analysts have commented on the company. HC Wainwright restated a "buy" rating and issued a $7.00 target price on shares of Anixa Biosciences in a research note on Tuesday, November 19th. D. Boral Capital reaffirmed a "buy" rating and set a $10.00 price objective on shares of Anixa Biosciences in a research note on Tuesday, November 19th.
View Our Latest Analysis on Anixa Biosciences
Anixa Biosciences Company Profile
(
Get Free Report)
Anixa Biosciences, Inc, a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer.
Read More
Before you consider Anixa Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anixa Biosciences wasn't on the list.
While Anixa Biosciences currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
